GlassScriptPhysician profile
David H Hoisington
NPI 1326093550
$6,644.82
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,467 · 2020: $2,334 · 2021: $1,844.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,529.37 | 2019-2021 | |
| Amgen INC. | $1,048.00 | 2019-2021 | |
| Novo Nordisk INC | $638.09 | 2019-2021 | |
| Glaxosmithkline, LLC. | $345.38 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.92 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $313.24 | 2019-2021 | |
| Lilly USA, LLC | $301.81 | 2019-2021 | |
| Amarin Pharma, INC. | $295.26 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $253.81 | 2019-2020 | |
| Pfizer INC. | $228.23 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $222.58 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $204.24 | 2021 | |
| Abbvie INC. | $147.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $87.60 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $87.30 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $65.36 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $58.15 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $53.92 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $47.64 | 2019-2021 | |
| Ibsa Pharma INC. | $45.21 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $36.23 | 2019 | |
| Esperion Therapeutics, INC. | $33.65 | 2020 | |
| Daiichi Sankyo INC. | $32.16 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.12 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.67 | 2021 | |
| Arbor Pharmaceuticals, INC. | $27.40 | 2019-2020 | |
| Amryt Pharma Holdings LTD | $18.74 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.51 | 2021 | |
| Bioventus LLC | $16.09 | 2019 | |
| Fortovia Therapeutics, INC. | $15.38 | 2020 | |
| Abbott Laboratories | $14.72 | 2021 | |
| Currax Pharmaceuticals LLC | $14.30 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.69 | 2019 | |
| Radius Health, INC. | $12.29 | 2020 | |
| Shire North American Group INC | $12.23 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.44 | 2021 | |
| Hologic Sales and Service, LLC | $10.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hoisington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.